Brightview In the News
Discover how BrightView is shaping the future of addiction treatment and impacting the lives of those in the communities we serve.
Accessible addiction treatment for African Americans
According to the CDC, overdose deaths among Black men increased more than 200% since 2015 and more than 144% among Black women. Even more troubling, a study by the Yale University Department of Psychiatry found that 90% of African American people in the U.S. who need addiction treatment do not get it.Doctor warns Kentucky of sedative 'Tranq' spreading across the country
A powerful sedative for large animals is being detected in a growing number of human overdose deaths. The drug is spreading across the country. It's called Xylazine. On the street, it’s known as "Tranq," "K," "Sleep Cut," or even "Zombie Drug." The DEA said it’s only authorized for use in the U.S. by veterinarians.Extended Conversations: Concerns over animal tranquilizer street drug
Fentanyl is deadly on its own and now it's being laced with more dangerous drug used as an animal tranquilizer.BrightView emphasizes importance of availability of naloxone
Community health organizations and law enforcement have been coming together in recent months in an effort to help prevent these deaths. A key part of that effort is increased access and availability of naloxone, a medication that can reverse overdoses involving heroin, fentanyl, and other opioids when given in time.
